Research review
Does fish oil help with diabetic neuropathy? What the research does and doesn't show
A 2025 Cochrane review found only two completed trials (87 people total) on omega-3 supplementation for diabetic peripheral neuropathy, rated low to very-low certainty, with little to no effect on nerve impairment, symptoms or quality of life.
The evidence doesn't support fish oil as a treatment for diabetic peripheral neuropathy. A 2025 Cochrane review found only two completed randomized trials on the question, together covering 87 people, and rated the evidence low to very-low certainty. Based on the larger of the two, six months of omega-3 supplementation may have little to no effect on the risk of developing nerve impairment, nerve-related symptoms, or quality of life compared with placebo.
What the evidence doesn't support
It doesn't support fish oil, at any dose or duration studied, as a treatment for diabetic peripheral neuropathy or its symptoms. It doesn't support fish oil as a way to prevent nerve damage from developing in people with diabetes — the one trial measuring that outcome found no meaningful difference from placebo. And it doesn't support a claim either way about pain specifically: the two available trials didn't report pain as an outcome at all, so there's no evidence on that question in either direction.
What the trials found
A 2025 Cochrane systematic review searched for every randomized controlled trial testing oral omega-3 supplements against placebo or no treatment in adults with diabetes (type 1, type 2, or impaired glucose tolerance) who had distal symmetrical peripheral neuropathy, excluding trials shorter than 180 days. It found only two completed trials meeting that bar, together covering 87 participants — a strikingly small evidence base for a question this common. Based on the larger trial (43 people with type 1 diabetes), six months of omega-3 supplementation may have little to no effect on the short-term risk of developing peripheral neuropathy impairment, on neuropathy symptom scores, or on health-related quality of life, compared with placebo — all rated low-certainty evidence. Pooling both trials for safety outcomes (78 participants), there was no clear difference in the risk of any adverse event or a serious adverse event between omega-3 and placebo, though that evidence was rated very low certainty. Neither trial reported data on pain specifically.
The review's own conclusion is blunt about the state of the evidence: there's inadequate data to draw conclusions either way, and what data exists points toward little or no benefit for symptoms or quality of life. No harms were flagged either, but the review says plainly that more data is needed even to rule those out with confidence.
Questions people ask
Does fish oil help nerve pain?
No trial in the current evidence measured pain as an outcome, so there's no research answer to that specific question. The two available trials looked at nerve impairment, symptom scores and quality of life, not pain directly.
Can fish oil help diabetic neuropathy?
The most relevant evidence — a 2025 Cochrane review of two small trials — found little to no effect on neuropathy impairment, symptoms, or quality of life from six months of omega-3 supplementation, and rated the evidence low certainty.
How much fish oil is needed for nerve health?
No effective dose has been established for peripheral neuropathy. The evidence base is two small trials, and the specific milligram dose used isn't detailed in the published review's summary.
When to talk to a doctor
Numbness, tingling, or pain in the feet or hands — especially with diabetes — is worth evaluating with a doctor, since peripheral neuropathy has established diagnostic tests and treatment options. Fish oil is not a treatment for peripheral neuropathy, and nothing in the evidence above supports using it as a substitute for medical evaluation or a prescribed treatment plan.
Related reading: fish oil benefits: what's established and what isn't and fish oil and inflammation: what the research does and doesn't show.
Sources
- Omega-3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus A 2025 Cochrane review found only two small trials (87 people total) testing omega-3 supplements for diabetic peripheral neuropathy, and rated the evidence low to very-low certainty, with little to no effect on nerve impairment, symptoms or quality of life.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.